Cancer Screening and Prevention Highlights in Gynecologic Cancer

Jeanine N Staples; Linda R Duska

doi:10.1016/j.ogc.2018.09.002

Cancer Screening and Prevention Highlights in Gynecologic Cancer

Obstet Gynecol Clin North Am. 2019 Mar;46(1):19-36. doi: 10.1016/j.ogc.2018.09.002.

Authors

Jeanine N Staples¹, Linda R Duska²

Affiliations

¹ Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of Virginia, University of Virginia Medical Center, PO Box 800712, Charlottesville, VA 22908, USA. Electronic address: js6qf@hscmail.mcc.virginia.edu.
² Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of Virginia, University of Virginia Medical Center, PO Box 800712, Charlottesville, VA 22908, USA.

PMID: 30683264
DOI: 10.1016/j.ogc.2018.09.002

Abstract

This article provides an up-to-date summary of screening approaches and key strategies in prevention of gynecologic malignancies. The Pap smear is the only proven screening intervention in the field of gynecologic oncology. Women should receive treatment for precancerous conditions of the cervix, vulva, vagina, and endometrial lining. Women with inherited conditions should consider having a risk-reducing surgery once they have finished childbearing. The human papilloma virus vaccination should be offered to all girls and boys aged 11 to 12 years, and can also be given as early as age 9 and through 26 years of age.

Keywords: HPV; Prevention; Screening; Vaccine.

Publication types

Review

MeSH terms

Early Detection of Cancer / statistics & numerical data*
Female
Genetic Predisposition to Disease
Genital Neoplasms, Female / diagnosis*
Genital Neoplasms, Female / prevention & control*
Health Services Accessibility
Humans
Mass Screening*
Papillomavirus Infections / diagnosis
Papillomavirus Infections / prevention & control
Papillomavirus Vaccines / therapeutic use*
Vaccination / statistics & numerical data*
Vaginal Smears
Women's Health*

Substances

Papillomavirus Vaccines